Albers J J, Chen C H, Adolphson J L
J Lipid Res. 1981 Nov;22(8):1206-13.
The relationship between plasma lecithin:cholesterol acyltransferase mass and enzyme activity and between mass and plasma cholesterol esterification rate was determined in 25 adult volunteers without overt disease (14 normolipidemic and 11 hyperlipidemic). Furthermore, the relationship of lecithin:cholesterol acyltransferase mass and cholesterol esterification rate to lipids, apoproteins, age, and ideal body weight was assessed. Lecithin:cholesterol acyltransferase mass determined by radioimmunoassay was highly correlated with enzyme activity assayed using a heated plasma substrate (r = 0.636) and with the molar cholesterol esterification rate determined either by radioassay (r = 0.809) or by measurement of the decrease of unesterified cholesterol (r = 0.621). Lecithin:cholesterol acyltransferase mass was also positively correlated with total cholesterol (r = 0.608), unesterified cholesterol (r = 0.562), age (r = 0.544), and percent ideal body weight (r = 0.619), but was not significantly correlated with log triglyceride, high density lipoprotein cholesterol, or apolipoproteins A-I, A-II, or D. Plasma cholesterol esterification rate by both methods was highly positively correlated with total cholesterol, unesterified cholesterol, log triglyceride, and age, but was inversely correlated with high density lipoprotein cholesterol. Upon partial correlation analysis with lecithin:cholesterol acyltransferase mass kept constant the cholesterol esterification rate remained significantly positively related to total cholesterol, unesterified cholesterol, and log triglyceride and inversely related to high density lipoprotein cholesterol. Two subjects had normal lecithin:cholesterol acyltransferase but approximately half normal molar cholesterol esterification rate. Measurement of lecithin:cholesterol acyltransferase mass and activity along with plasma cholesterol esterification rate will permit differentiation of abnormalities of enzyme from qualitative or quantitative substrate or cofactor abnormalities. Also, the finding that the regression line between LCAT mass and the plasma esterification rate by direct determination of unesterified cholesterol passes through the origin suggests that all immunodetectable LCAT in plasma is active in normal subjects.-Albers, J. J., C-H. Chen, and J. L. Adolphson. Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
在25名无明显疾病的成年志愿者(14名血脂正常者和11名高脂血症患者)中,测定了血浆卵磷脂:胆固醇酰基转移酶质量与酶活性之间以及质量与血浆胆固醇酯化率之间的关系。此外,还评估了卵磷脂:胆固醇酰基转移酶质量和胆固醇酯化率与血脂、载脂蛋白、年龄和理想体重的关系。通过放射免疫测定法测定的卵磷脂:胆固醇酰基转移酶质量与使用加热血浆底物测定的酶活性高度相关(r = 0.636),与通过放射测定法(r = 0.809)或通过测量未酯化胆固醇的减少量(r = 0.621)测定的摩尔胆固醇酯化率高度相关。卵磷脂:胆固醇酰基转移酶质量也与总胆固醇(r = 0.608)、未酯化胆固醇(r = 0.562)、年龄(r = 0.544)和理想体重百分比(r = 0.619)呈正相关,但与甘油三酯对数、高密度脂蛋白胆固醇或载脂蛋白A-I、A-II或D无显著相关性。两种方法测定的血浆胆固醇酯化率与总胆固醇、未酯化胆固醇、甘油三酯对数和年龄高度正相关,但与高密度脂蛋白胆固醇呈负相关。在保持卵磷脂:胆固醇酰基转移酶质量不变的偏相关分析中,胆固醇酯化率仍与总胆固醇、未酯化胆固醇和甘油三酯对数显著正相关,与高密度脂蛋白胆固醇呈负相关。两名受试者的卵磷脂:胆固醇酰基转移酶正常,但摩尔胆固醇酯化率约为正常的一半。同时测定卵磷脂:胆固醇酰基转移酶质量和活性以及血浆胆固醇酯化率,将有助于区分酶异常与定性或定量底物或辅因子异常。此外,通过直接测定未酯化胆固醇发现卵磷脂胆固醇酰基转移酶质量与血浆酯化率之间的回归线经过原点,这表明血浆中所有免疫可检测到的卵磷脂胆固醇酰基转移酶在正常受试者中都是有活性的。-阿尔伯斯,J. J.,陈C-H,和J. L. 阿道夫森。卵磷脂:胆固醇酰基转移酶(LCAT)质量;其与LCAT活性和胆固醇酯化率的关系。